Online Producer, New Delhi
Aditya's Feed
Oct 14, 2015

Drug retailers protest against e-pharmacies

NEW DELHI/MUMBAI (Reuters) – Drug retailers shut up shop for the day on Wednesday to protest against the country’s growing online pharmacy industry, and threatened to close indefinitely if the federal government did not shut down e-pharmacies.

The nationwide protest was widely supported, with as many as 850,000 chemists closing their doors, leaving patients waiting in long queues at any pharmacies that were open.

Oct 14, 2015

Indian drug retailers protest against e-pharmacies

NEW DELHI/MUMBAI, Oct 14 (Reuters) – Indian drug retailers
shut up shop for the day on Wednesday to protest against the
country’s growing online pharmacy industry, and threatened to
close indefinitely if the federal government did not shut down
e-pharmacies.

The nationwide protest was widely supported, with as many as
850,000 chemists closing their doors, leaving patients waiting
in long queues at any pharmacies that were open.

Oct 14, 2015

India battles big pharma over cough syrup abuse, reducing supplies

NEW DELHI, Oct 14 (Reuters) – Indian regulators are
privately pressuring major drug firms to better police how they
sell popular codeine-based cough syrups to tackle smuggling and
addiction, a move that is reducing supplies of a medicine
doctors say is an effective treatment.

India’s Cipla stopped making the product last year
owing to regulatory demands, and U.S.-based Abbott Laboratories
and Pfizer have had to reduce batch sizes by up
to half, cutting how much medicine their factories can produce.

Oct 13, 2015

Exclusive: India battles big pharma over cough syrup abuse, reducing supplies

NEW DELHI (Reuters) – Indian regulators are privately pressuring major drug firms to better police how they sell popular codeine-based cough syrups to tackle smuggling and addiction, a move that is reducing supplies of a medicine doctors say is an effective treatment. India’s Cipla (CIPL.NS: Quote, Profile, Research, Stock Buzz) stopped making the product last year owing to regulatory demands, and U.S.-based Abbott Laboratories (ABT.N: Quote, Profile, Research, Stock Buzz) and Pfizer (PFE.N: Quote, Profile, Research, Stock Buzz) have had to reduce batch sizes by up to half, cutting how much medicine their factories can produce.

But they are pushing back against other demands, a Reuters review of correspondence between companies and regulators showed, including selling one batch to only one buyer and printing labels that specify where the drug would be sold. Regulators want to make it easier for law enforcement agencies to track cough syrup abuse in the country and bottles smuggled to neighbouring Bangladesh, where it was banned in the 1980s but is still sought by addicts.

Oct 10, 2015

OFFICIAL CORRECTION: India’s drug stores plan protest against e-pharmacies

NEW DELHI/MUMBAI (Reuters) – As many as 850,000 small chemist shops in India will shut for a day next week to protest against a burgeoning online pharmacy industry that is attracting big money backers.

Healthcare provider Apollo Hospitals Enterprise Ltd plans to start online drug sales in India, while Zigy, and Sequoia Capital-backed 1mg already have e-pharmacies to tap a retail market IMS Health says is worth about $13 billion.

Oct 10, 2015

Interview: India risks backsliding on success against HIV – U.N. envoy

NEW DELHI (Reuters) – New HIV infections in India could rise for the first time in more than a decade because states are mismanaging a prevention programme by delaying payments to health workers, the United Nations envoy for AIDS in Asia and the Pacific said.

India’s efforts to fight HIV have for years centred around community-based programmes run for people at high risk of contracting the virus, such as sex workers and injecting drug users. The results won praise globally – annual new infections fell consistently and, overall, were reduced by more than half between 2000 and 2011.

Oct 10, 2015

India risks backsliding on success against HIV-U.N. envoy

NEW DELHI (Reuters) – New HIV infections in India could rise for the first time in more than a decade because states are mismanaging a prevention program by delaying payments to health workers, the United Nations envoy for AIDS in Asia and the Pacific said.

India’s efforts to fight HIV have for years centered around community-based programs run for people at high risk of contracting the virus, such as sex workers and injecting drug users. The results won praise globally – annual new infections fell consistently and, overall, were reduced by more than half between 2000 and 2011.

Oct 9, 2015

India’s drug stores plan protest against e-pharmacies

NEW DELHI/MUMBAI (Reuters) – As many as 850,000 small chemist shops in India will shut for a day next week to protest against a burgeoning online pharmacy industry that is attracting big money backers.

Healthcare provider Apollo Hospitals Enterprise Ltd plans to start online drug sales in India, while Zigy, and Sequoia Capital-backed 1mg already have e-pharmacies to tap a retail market IMS Health says is worth about $13 billion.

Oct 6, 2015

Choking Delhi vows pollution tax, car-free days to improve air

NEW DELHI (Reuters) – India’s polluted capital, New Delhi, will within two months impose a tax on commercial vehicles entering the city and prohibit the use of cars on certain busy routes once every month, its transport minister said on Tuesday.

High pollution levels have worried environmentalists, public and the authorities in the city of 16 million people, which the World Health Organization last year said had the worst air quality in the world. India rejected the report’s findings.

Sep 14, 2015

Abbott tangles with regulators over Indian cough syrup complaint

NEW DELHI (Reuters) – Drugmaker Abbott Healthcare is
challenging an Indian state’s accusation that a sample of the
company’s cough syrup contained excessive levels of codeine, the
second multinational to question India’s regulatory testing
regime in recent months.

Whether the sample of Abbott’s popular “Phensedyl” was a
genuine product or a fake has not been established, but the
suspect batch of 80,000 bottles has not been recalled.

    • About Aditya

      "Aditya is part of the India politics, economy and general news team at the Reuters bureau in New Delhi. He writes on a range of topics but focusses on India's healthcare space. After joining Reuters in July 2008, he spent nearly six years managing content and writing for the Reuters.com India edition. Follow him on Twitter @adityakalra"
      Joined Reuters:
      July 2008
    • Contact Aditya

    • Follow Aditya